News Image

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

Provided By GlobeNewswire

Last update: Oct 30, 2024

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients

Read more at globenewswire.com

IRHYTHM TECHNOLOGIES INC

NASDAQ:IRTC (3/3/2025, 8:00:02 PM)

Premarket: 107.6 -1.5 (-1.37%)

109.1

-1.06 (-0.96%)



Find more stocks in the Stock Screener

Follow ChartMill for more